Skip to main content

Great Ormond Street Hospital for Children NHS Trust UCL Institute of Child Health
 

Clinical information

GOSH logo

ECMO guidelines NEEDS REVIEW

This clinical guideline was due to for review on 1 March 2008 and therefore may not reflect current practice at Great Ormond Street Hospital. This guideline is for reference only. For advice on current practice please contact Liz Smith.

Management

This page contains all of the ECMO guidelines.

Factsheet icon A factsheet about ECMO is available for families here.

Please click on the link below:

01 Cannulation for VA ECMO (Word document, 19 KB)

02 Heparin Administration (Word document, 17 KB)

03 LR ACT (Word document, 13 KB)

04 Blood and blood product protocol (Word document, 26 KB)

05 Start of ECLS - Roller Pump (Word document, 15 KB)

06 Blood sampling from the ECLS circuit (Word document, 13 KB)

07 CAPS (Word document, 15 KB)

08 To come off ECLS in emergencies - roller (Word document, 13 KB)

09 To restart ECLS - Roller Pump (Word document, 24 KB)

10 Loss of Electrical Power (Word document, 12 KB)

11 Membrane oxygenator - general (Word document, 15 KB)

15 Quadrox Jostra Oxygenator (Word document, 13 KB)

16 Medos Oxygenators (Word document, 15 KB)

17 Sedation of neonates  children during ECMO (Word document, 14 KB)

18 Selection of patients for Veo-venous ( V-V ) ECLS (Word document, 13 KB)

19 Management of VV ECLS (Word document, 17 KB)

20 VV Weaning prot (Word document, 17 KB)

21 Cannulae removal Semi Seldinger (Word document, 32 KB)

22 Conversion VV - VA ECLS (Word document, 16 KB)

23 Weaning from VA ECMO - roller (Word document, 37 KB)

24V-A-V ECLS (Word document, 18 KB)

25 Roller pump- open bridge technique (Word document, 16 KB)

26 S3 roller pump protocol (Word document, 13 KB)

27 Cardiac ECLS Protocol (Word document, 30 KB)

28 Angiograms on ECLS (Word document, 18 KB)

29 Invasive procedures on ECLS (Word document, 13 KB)

30 ECLS circuit changes (Word document, 14 KB)

31 Haemofilatration - General Points (Word document, 12 KB)

32 Haemofiltration&ECMOIris (Word document, 14 KB)

33 Use of the Biomedicus Centrifugal Pump (Word document, 18 KB)

34 Pressure Isolator - Biomedicus Pump (Word document, 15 KB)

35 Plasma Free Haemoglobin (Word document, 13 KB)

36 Biomed Open Bridge (Word document, 16 KB)

37 Biomedicus weaning (Word document, 18 KB)

38 X ray protocol for ECMO (Word document, 12 KB)

41 Protocol Deviations (Word document, 5 KB)

42 ECMO cannula care protocol (Word document, 23 KB)

References/Bibliography

Reference 1:
Van Meurs K, Lally KP, Peek G, Zwischenberger JB (2005) ECMO: Extracorporeal Cardiopulmonary Support in Critical Care (The "Red Book"), Third Edition. Michigan, Extracorporeal Life Support Organization

Document control information

Lead author(s)
Name Liz Smith Position ECMO coordinator Dept/speciality Cardiac Intensive Care
Document owner
Name Liz Smith Position ECMO coordinator Dept/speciality Cardiac Intensive Care
Approved by
Name Allan Goldman Position Consultant Intensivist, Lead ECMO Clinician Dept/speciality Cardiac Intensive Care

Literature review undertaken no
Audit/evaluation of current practice undertaken no
All staff groups involved in the care of these patients have had input into the development/review no

First introduced 1 July 1999 Review schedule Two years
Date approved 1 March 2006 Next review 1 March 2008
Document version 1.0 Replaces version n/a
These guidelines are intended to guide and facilitate the care of patients at Great Ormond Street Hospital for Children NHS Trust (GOSH). The guidance contained therein is not intended to replace individual assessment and personalised treatment of the patient. The authors attempt to base the guidance on best available evidence and ensure that content is up to date. The guidelines may not necessarily represent the views of all clinicians at GOSH. This information may be used for private education, research and institutional education but if used for any other purposes, consent must first be obtained from GOSH. Any person intending to use the guidelines should assess the suitability of use. GOSH will not accept any responsibility for use by external agencies or individuals. No part of this publication may be reproduced, stored in or introduced into a retrieval system or transmitted in any form without prior consent and acknowledgment of GOSH. GOSH retains copyright.

In some guidelines it is necessary to use product names to ensure clarity of information or for the purpose of identifying a specific type of product or drug. Where possible, generic product names have been used in preference to trade names or trade marks. Please be aware that use of any trade names listed in this document should not necessarily be seen as an endorsement of the product and that other similar products may be available.


This page was last reviewed on 22 October 08 12:33